Our study is very unique compared to other reports since we selected the ESCC esophagectomy samples without neoadjuvant chemoradiotherapy, which excluded the possible treatment effect on PD-L1 expression. This evidence concerns the gene CD274 and esophageal squamous cell carcinoma.